Header Logo

Connection

Stefania Gallucci to Protein Kinase Inhibitors

This is a "connection" page, showing publications Stefania Gallucci has written about Protein Kinase Inhibitors.
Connection Strength

0.853
  1. Gallo PM, Chain RW, Xu J, Whiteman LM, Palladino A, Caricchio R, Costa-Reis P, Sullivan KE, Gallucci S. EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon a-accelerated murine lupus. Int Immunopharmacol. 2024 Oct 25; 140:112692.
    View in: PubMed
    Score: 0.853
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.